Last 12 months
Inside the activity.
1 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 13 |
| Mar 2026 | 1 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 26, 2018 Filed Sep 28, 2018 21:04 UTC |
Taylor IanSenior Vice President, Biology
|
GrantStock Option (right to buy) · Derivative | 23,390 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025562 · doc4.xml · derivative · entry 1 Taylor Ian · CIK 0001753281 · Senior Vice President, Biology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,390 Underlying: Common Stock · 23,390 shares Expires 2028-09-25 F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 1, 2017, with the remainder of the shares vesting in equal monthly installments following June 1, 2017 through June 1, 2020. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 01:13 UTC |
Kennedy Edward Moore Jr.Director
|
GrantStock Option (right to buy) · Derivative | 32,870 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025564 · doc4.xml · derivative · entry 1 Kennedy Edward Moore Jr. · CIK 0001753859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,870 Underlying: Common Stock · 32,870 shares Expires 2028-09-25 F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/12 of the shares underlying the award vested as of July 3, 2018, with the remainder of the shares vesting in equal quarterly installments following July 3, 2018 through April 3, 2021. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:51 UTC |
Crews Craig Martin10% owner
|
OtherStock Option (right to buy) · Derivative | 203,790 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025556 · doc4.xml · derivative · entry 2 Crews Craig Martin · CIK 0001753781 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,790 Underlying: Common Stock · 203,790 shares Expires 2028-09-25 F1 · kind: These option awards were granted to the Reporting Person under the Issuer's 2018 Stock Incentive Plan in consideration for consulting services. The Reporting Person beneficially owns more than 10% of the outstanding stock of the Issuer. F2 · derivative.exercise_date: These option awards were granted on September 26, 2018 and the shares underlying the awards shall vest in equal quarterly installments following September 26, 2018 through September 26, 2021. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:51 UTC |
Crews Craig Martin10% owner
|
OtherStock Option (right to buy) · Derivative | 31,360 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025556 · doc4.xml · derivative · entry 1 Crews Craig Martin · CIK 0001753781 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,360 Underlying: Common Stock · 31,360 shares Expires 2028-09-25 F1 · kind: These option awards were granted to the Reporting Person under the Issuer's 2018 Stock Incentive Plan in consideration for consulting services. The Reporting Person beneficially owns more than 10% of the outstanding stock of the Issuer. F2 · derivative.exercise_date: These option awards were granted on September 26, 2018 and the shares underlying the awards shall vest in equal quarterly installments following September 26, 2018 through September 26, 2021. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC |
Cassidy Sean AChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 27,330 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 6 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,330 Underlying: Common Stock · 27,330 shares Expires 2028-09-25 F6 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC |
Cassidy Sean AChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 81,770 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 5 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,770 Underlying: Common Stock · 81,770 shares Expires 2028-09-25 F5 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC |
Cassidy Sean AChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 5,200 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Underlying: Common Stock · 5,200 shares Expires 2028-09-25 F4 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC |
Cassidy Sean AChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 15,160 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,160 Underlying: Common Stock · 15,160 shares Expires 2028-09-25 F3 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017, with the remainder of the shares vesting in equal monthly installments following January 1, 2017 through January 1, 2020. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC |
Cassidy Sean AChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 31,710 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,710 Underlying: Common Stock · 31,710 shares Expires 2028-09-25 F2 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC |
Cassidy Sean AChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 1,980 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,980 Underlying: Common Stock · 1,980 shares Expires 2028-09-25 F1 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:38 UTC |
Morrison BriggsDirector
|
GrantStock Option (right to buy) · Derivative | 32,870 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025547 · doc4.xml · derivative · entry 2 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,870 Underlying: Common Stock · 32,870 shares Expires 2028-09-25 F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/12 of the shares underlying the award vested as of June 28, 2018, with the reminder of the shares vesting in equal quarterly installments following June 28, 2018 through March 28, 2021. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:38 UTC |
Morrison BriggsDirector
|
GrantStock Option (right to buy) · Derivative | 6,960 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025547 · doc4.xml · derivative · entry 1 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,960 Underlying: Common Stock · 6,960 shares Expires 2028-09-25 F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of September 1, 2017, with the remainder of the shares vesting in equal monthly installments following September 1, 2017 through September 1, 2020. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 01:02 UTC |
Margus Bradley AlbertDirector
|
GrantStock Option (right to buy) · Derivative | 4,660 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025560 · doc4.xml · derivative · entry 4 Margus Bradley Albert · CIK 0001753491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,660 Underlying: Common Stock · 4,660 shares Expires 2028-09-25 F4 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/12 of the shares underlying the award vested as of December 14, 2017, with the remainder of the shares vesting in equal quarterly installments following December 14, 2017 through September 14, 2020. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 01:02 UTC |
Margus Bradley AlbertDirector
|
GrantStock Option (right to buy) · Derivative | 4,560 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025560 · doc4.xml · derivative · entry 3 Margus Bradley Albert · CIK 0001753491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,560 Underlying: Common Stock · 4,560 shares Expires 2028-09-25 F3 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 01:02 UTC |
Margus Bradley AlbertDirector
|
GrantStock Option (right to buy) · Derivative | 4,660 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025560 · doc4.xml · derivative · entry 2 Margus Bradley Albert · CIK 0001753491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,660 Underlying: Common Stock · 4,660 shares Expires 2028-09-25 F2 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 01:02 UTC |
Margus Bradley AlbertDirector
|
GrantStock Option (right to buy) · Derivative | 14,270 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025560 · doc4.xml · derivative · entry 1 Margus Bradley Albert · CIK 0001753491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,270 Underlying: Common Stock · 14,270 shares Expires 2028-09-25 F1 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:39 UTC |
Crew AndrewSee Remarks
|
GrantStock Option (right to buy) · Derivative | 5,110 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025549 · doc4.xml · derivative · entry 7 Crew Andrew · CIK 0001753292 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 5,110 Underlying: Common Stock · 5,110 shares Expires 2028-09-25 F7 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on April 9, 2019, with the remainder of the shares vesting in equal monthly installments following April 9, 2019 through April 9, 2022. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:39 UTC |
Crew AndrewSee Remarks
|
GrantStock Option (right to buy) · Derivative | 34,550 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025549 · doc4.xml · derivative · entry 6 Crew Andrew · CIK 0001753292 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,550 Underlying: Common Stock · 34,550 shares Expires 2028-09-25 F6 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:39 UTC |
Crew AndrewSee Remarks
|
GrantStock Option (right to buy) · Derivative | 20,440 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025549 · doc4.xml · derivative · entry 5 Crew Andrew · CIK 0001753292 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,440 Underlying: Common Stock · 20,440 shares Expires 2028-09-25 F5 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:39 UTC |
Crew AndrewSee Remarks
|
GrantStock Option (right to buy) · Derivative | 2,600 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025549 · doc4.xml · derivative · entry 4 Crew Andrew · CIK 0001753292 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 2,600 shares Expires 2028-09-25 F4 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:39 UTC |
Crew AndrewSee Remarks
|
GrantStock Option (right to buy) · Derivative | 5,340 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025549 · doc4.xml · derivative · entry 3 Crew Andrew · CIK 0001753292 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,340 Underlying: Common Stock · 5,340 shares Expires 2028-09-25 F3 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of December 13, 2017, with the remainder of the shares vesting in equal monthly installments following December 13, 2017 through December 13, 2020. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:39 UTC |
Crew AndrewSee Remarks
|
GrantStock Option (right to buy) · Derivative | 10,390 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025549 · doc4.xml · derivative · entry 2 Crew Andrew · CIK 0001753292 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,390 Underlying: Common Stock · 10,390 shares Expires 2028-09-25 F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017, with the remainder of the shares vesting in equal monthly installments following January 1, 2017 through January 1, 2020. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:39 UTC |
Crew AndrewSee Remarks
|
GrantStock Option (right to buy) · Derivative | 15,860 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025549 · doc4.xml · derivative · entry 1 Crew Andrew · CIK 0001753292 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,860 Underlying: Common Stock · 15,860 shares Expires 2028-09-25 F1 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:47 UTC |
Houston John GDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 132,880 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025553 · doc4.xml · derivative · entry 5 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,880 Underlying: Common Stock · 132,880 shares Expires 2028-09-25 F5 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:47 UTC |
Houston John GDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 200,440 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025553 · doc4.xml · derivative · entry 4 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,440 Underlying: Common Stock · 200,440 shares Expires 2028-09-25 F4 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of September 15, 2018, with the remainder of the shares vesting in equal monthly installments following September 15, 2018 through September 15, 2021. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:47 UTC |
Houston John GDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 13,360 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025553 · doc4.xml · derivative · entry 3 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,360 Underlying: Common Stock · 13,360 shares Expires 2028-09-25 F3 · derivative.exercise_date: This option award was granted on September 26, 2018 and will vest upon achievement of a regulatory milestone for the Issuer's estrogen receptor program. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:47 UTC |
Houston John GDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 13,360 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025553 · doc4.xml · derivative · entry 2 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,360 Underlying: Common Stock · 13,360 shares Expires 2028-09-25 F2 · derivative.exercise_date: This option award was granted on September 26, 2018 and will vest upon achievement of a regulatory milestone for the Issuer's androgen receptor program. Read SEC document |
| September 26, 2018 Filed Sep 29, 2018 00:47 UTC |
Houston John GDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 106,900 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025553 · doc4.xml · derivative · entry 1 Houston John G · CIK 0001753537 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,900 Underlying: Common Stock · 106,900 shares Expires 2028-09-25 F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 5, 2018, with the remainder of the shares vesting in equal monthly installments following January 5, 2018 through January 5, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.